Total Payments
$380,149
2024 Payments
$82,494
Companies
28
Transactions
1,071
Medicare Patients
491
Medicare Billing
$130,867
Payment Breakdown by Category
Other$270,693 (71.2%)
Travel$52,801 (13.9%)
Consulting$35,718 (9.4%)
Food & Beverage$20,813 (5.5%)
Education$123.78 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $270,693 | 142 | 71.2% |
| Travel and Lodging | $52,801 | 288 | 13.9% |
| Consulting Fee | $35,718 | 11 | 9.4% |
| Food and Beverage | $20,813 | 624 | 5.5% |
| Education | $123.78 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IRONSHORE PHARMACEUTICALS INC. | $159,397 | 394 | $0 (2024) |
| Allergan, Inc. | $59,688 | 187 | $0 (2021) |
| Shire North American Group Inc | $52,447 | 115 | $0 (2019) |
| Neos Therapeutics, LP | $43,103 | 95 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $27,350 | 60 | $0 (2024) |
| ABBVIE INC. | $24,789 | 72 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $6,387 | 15 | $0 (2017) |
| Neuronetics, Inc. | $2,193 | 3 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,078 | 28 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $584.05 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82,494 | 237 | IRONSHORE PHARMACEUTICALS INC. ($75,668) |
| 2023 | $72,630 | 218 | Ironshore Pharmaceuticals Inc. ($55,228) |
| 2022 | $24,073 | 48 | Ironshore Pharmaceuticals Inc. ($23,493) |
| 2021 | $11,018 | 55 | AbbVie Inc. ($4,584) |
| 2020 | $11,782 | 55 | Allergan, Inc. ($11,101) |
| 2019 | $31,112 | 91 | Allergan Inc. ($14,726) |
| 2018 | $86,140 | 212 | Shire North American Group Inc ($35,099) |
| 2017 | $60,900 | 155 | Allergan Inc. ($24,664) |
All Payment Transactions
1,071 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $61.03 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $34.07 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/24/2024 | Vertical Pharmaceuticals, LLC | Relexxii (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Neurology - ADHD medication | ||||||
| 10/22/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Travel and Lodging | Cash or cash equivalent | $217.28 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/22/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Travel and Lodging | Cash or cash equivalent | $167.40 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/22/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Travel and Lodging | Cash or cash equivalent | $105.26 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/22/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $58.43 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/22/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/22/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/16/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $820.00 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $53.33 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 20 | 132 | $26,400 | $11,528 |
| 2022 | 2 | 45 | 162 | $30,650 | $12,035 |
| 2021 | 4 | 173 | 586 | $106,200 | $35,991 |
| 2020 | 7 | 253 | 1,289 | $212,730 | $71,312 |
Total Patients
491
Total Services
2,169
Medicare Billing
$130,867
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 132 | $26,400 | $11,528 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 127 | $25,400 | $10,307 | 40.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 15 | 35 | $5,250 | $1,728 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 253 | $50,600 | $19,647 | 38.8% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 72 | 187 | $28,000 | $8,356 | 29.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 13 | 82 | $16,400 | $5,360 | 32.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 64 | $11,200 | $2,628 | 23.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 72 | 399 | $59,850 | $21,830 | 36.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 53 | 283 | $56,600 | $19,579 | 34.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 304 | $53,200 | $13,823 | 26.0% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 18 | 125 | $25,000 | $8,649 | 34.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 24 | 24 | $8,400 | $3,570 | 42.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 19 | 20 | $7,000 | $2,307 | 33.0% |
| 90785 | Interactive complexity | Office | 2020 | 14 | 134 | $2,680 | $1,555 | 58.0% |
About Dr. Maitri Patel, MD
Dr. Maitri Patel, MD is a Child & Adolescent Psychiatry healthcare provider based in Framingham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912945213.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maitri Patel, MD has received a total of $380,149 in payments from pharmaceutical and medical device companies, with $82,494 received in 2024. These payments were reported across 1,071 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($270,693).
As a Medicare-enrolled provider, Patel has provided services to 491 Medicare beneficiaries, totaling 2,169 services with total Medicare billing of $130,867. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Location Framingham, MA
- Active Since 06/02/2006
- Last Updated 10/02/2023
- Taxonomy Code 2084P0804X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912945213
Products in Payments
- JORNAY PM (Drug) $154,623
- VRAYLAR (Drug) $84,347
- MYDAYIS (Drug) $44,313
- Adzenys XR-ODT (Drug) $43,082
- Trintellix (Drug) $24,187
- Vyvanse (Drug) $5,506
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $4,774
- VYVANSE (Drug) $3,960
- NEUROSTAR TMS THERAPY SYSTEM (Device) $2,154
- REXULTI (Drug) $723.30
- INGREZZA (Drug) $584.05
- LATUDA (Drug) $495.61
- ARISTADA (Drug) $413.77
- CAPLYTA (Drug) $328.95
- Qelbree (Drug) $283.72
- ABILIFY MAINTENA (Drug) $276.68
- SPRAVATO (Drug) $261.76
- INVEGA SUSTENNA (Drug) $251.68
- TRINTELLIX (Drug) $244.26
- AUSTEDO (Drug) $121.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.